Study suggests convalescent plasma may be safe COVID-19 treatment

In a small study of 14 infants and children, convalescent plasma from patients who recovered from COVID-19 infection provided expected antibody levels and raised no safety concerns

Frontiers The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis

Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters - eBioMedicine

NIH clinical trial explores use of convalescent plasma in at-risk outpatients with early COVID-19

Trial of COVID-19 blood plasma finds no benefit in severely ill patients

Early treatment with convalescent plasma for COVID-19 doesn't show benefit

Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study, Journal of Translational Medicine

Convalescent Plasma Is Safe to Treat Covid-19, National Study Shows - WSJ

Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children

Standardized two-step testing of antibody activity in COVID-19 convalescent plasma - ScienceDirect

Coronavirus survivor plasma is safe, large study finds